← Return to Multiparametric MRI (mpMRI) over diagnosis?
DiscussionMultiparametric MRI (mpMRI) over diagnosis?
Prostate Cancer | Last Active: Dec 14, 2023 | Replies (32)Comment receiving replies
Replies to "Gentlemen: These are truly your choices and I respect them. I had no problems with my..."
Thanks for a thoughtful and detailed description of your experience!
PCa is a disease that is best understood to be a sliding scale of severity for the majority of older men.
This is due to the history of how it was originally defined and treated and what is now understood, in 2023, by specialists on the cutting edge of the field today.
My comment that 3+3 Gleason NEVER metastasizes is based on the latest work of Dr. Matt Cooperberg and his colleagues (there are others).
In fact, there is a serious debate to rename Gleason 6, see the following website to read both sides of the debate:
https://www.urotoday.com/conference-highlights/aua-2023/aua-2023-prostate-cancer/144054-aua-2023-debate-renaming-gleason-6-prostate-cancer.html
Excerpt below:
“On that note, Dr. Cooperberg took over and titled his talk “Its Time to Rename Gleason 6.”
Cancer (from the Latin) implies insidious growth and spread – and nomenclature matters.
In a recent paper and call to action by him and colleagues (Eggener et al. JCO 2022), they make the following key points:
- Gleason 6 is extremely prevalent. Diagnosis is often incidental to BPH and other factors related to BPH (ie elevated PSA, urology visits)
- Gleason 6 never metastasizes
- Gleason 6 has few, if any, molecular hallmarks of cancer
- AS is still done highly inconsistently
- “Gleason 6” as a non-cancer would still require surveillance
- The harm: benefit ratio of screening is improved the less we overdiagnose low-grade disease”
At the end of the day, every man facing the vagaries of PCa, needs to be satisfied (and hopefully thankful) for whatever plan or treatment they decide upon with their doctor(s).